English · Not set Change ▾

Live scores ticker: On · Turn off

Markets ticker: On · Turn off

Saved in a cookie on this device (and in your account when you are logged in). We never store your IP address.

Entities › org

AMP

19 headlines · 9 outlets · 2026-10-06 → 2026-11-06 · Wikipedia ↗ · 🔒 Follow

Latest coverage

PR Newswire: Health ·yesterday ☆

Press releases
Country: United States

New England Biolabs® spotlights multiomic profiling of cell-free DNA (cfDNA) and cell-free RNA (cfRNA) at the AMP 2026 Annual Meeting & Expo in Seattle, Washington

Leveraging over 50 years of expertise in enzymology, NEB® shares insights on reagents and workflows for molecular diagnostics, including cfDNA & cfRNA analysis, enzymatic methylation profiling, and high-fidelity PCR. IPSWICH, Mass., Nov. 6, 2026 /PRNewswire/ -- New England Biolabs (NEB),...

Health Details Archived copy ↗

PR Newswire: Health ·Nov 5, 2026 ☆

Press releases
Country: United States

Nabsys to Highlight Electronic Genome Mapping Findings from Leading Hematopathology Experts at AMP 2026

Researchers from Augusta University and The University of Texas MD Anderson Cancer Center to present findings on structural variant detection in hematologic malignancies with EGM PROVIDENCE, R.I., Nov. 5, 2026 /PRNewswire/ -- Nabsys 2.0, LLC ("Nabsys") today announced that researchers...

Health Science Details Archived copy ↗

bioRxiv ·Nov 2, 2026 ☆

University / research
Country: United States

Beyond a single threshold: calibration of CADD v1.7 and AlphaGenome for ACMG/AMP computational evidence across variant classes, model versions, and reference data

Clinical laboratories use computational predictors as supporting evidence for or against pathogenicity under the ACMG/AMP guidelines, but this evidence is reliable only when score thresholds are calibrated. Genome-wide predictors such as CADD are often applied using a single cutoff across all…

Science Details Archived copy ↗

AMP

Latest coverage

New England Biolabs® spotlights multiomic profiling of cell-free DNA (cfDNA) and cell-free RNA (cfRNA) at the AMP 2026 Annual Meeting & Expo in Seattle, Washington

Nabsys to Highlight Electronic Genome Mapping Findings from Leading Hematopathology Experts at AMP 2026

Beyond a single threshold: calibration of CADD v1.7 and AlphaGenome for ACMG/AMP computational evidence across variant classes, model versions, and reference data

Explore

News

Daily

Banana Watch & guides

Elections 2026

Watch & listen

Sports

Local & weather

Understand & explore

Join

Banana News

Upgrade to unlock this

Keyboard shortcuts

Move

Go

Everywhere

Ask Ara